Joined October 2020
- Tweets 26
- Following 412
- Followers 104
- Likes 757
1 Photos and videos
Jun 6
RT @ttborgtr: Kadınları ve Kürtleri Aşağılayan, Hekimlik Meslek Onurunu Hedef Alan Çirkin Sözleri Kınıyoruz
Dün İzmir’deki bir özel hastan…
430
Murat Çap, MD retweeted
The recent RCA stenosis and SCD paper is a good teaching example. Through a single study, we can discuss time zero, immortal time, prediction vs. causality, confounders, mediators, colliders, overadjustment, etc..
5
11
50
11,486
Murat Çap, MD retweeted
4
16
48
43,156
Murat Çap, MD retweeted
A Practical Guide to Interpret an RCT
Underpowered ≠ Inconclusive ≠ Negative ≠ Neutral
1
33
90
19,560
Murat Çap, MD retweeted
📌Excellent analysis of IVUS CHIP & OPTIMAL by @ihtanboga
Mar 31
I’m still living in the world of the meta-analysis published just last week😁before IVUS-CHIP and OPTIMAL. Keep using IVUS!
2
5
902
Murat Çap, MD retweeted
4
12
1,672
Murat Çap, MD retweeted
Absolutely brilliant analysis, a must read...
3
6
972
Murat Çap, MD retweeted
I would just refer everyone to this very thorough analysis by @ihtanboga 👇
x.com/ihtanboga/status/20391…
6
20
3,953
Murat Çap, MD retweeted
Mar 31
1
33
76
20,706
Murat Çap, MD retweeted
Mar 23
Thank you @realarainmd for posing such a thought-provoking question.
I believe that ORBITA-CTO is eagerly awaited by all cardiologists, especially those in the CTO community. Many CTO operators are expecting a result that supports their perspective that CTO opening offers benefits beyond a placebo effect. However, regardless of the outcome, the debate is likely to continue.
I would also like to specifically thank @rallamee for introducing the concept of “ORBITA-like” into the medical literature.
2/
1
2
10
4,665
Murat Çap, MD retweeted
Mar 21
IVI use being associated with such benefit in the very early period (first 3-5 days) is clinically implausible.
In addition to your points, I would add the following:
- Key claim: IVI-PCI ≈ CABG
- But the data come from 3 very different sources, and the mixing creates serious bias concerns.
1/
Mar 21
PCI vs. PCI - More reflections on the study by Gim et al
The sticking point for me (and others like @aymanka, @ihtanboga, @GreggWStone) is the immediate separation of the curves bet. the PCI arms.
It is difficult to see how immortal time bias alone accounts for this.
doi: 10.1016/j.jcin.2025.11.036
1
3
15
3,473
Murat Çap, MD retweeted
The best breakdown and analysis thus far of CLOSURE-AF👇👇👇
7
13
5,268
Murat Çap, MD retweeted
Mar 19
3
49
116
23,274
A must read if you haven’t read it yet.
8
36
10,272
Murat Çap, MD retweeted
Mar 16
I am blown away by this entire thread! 😳🥹🔥
Thank you for the education @ihtanboga! This entire thread is priceless. 🙏🏼
6
12
2,890
Murat Çap, MD retweeted
Mar 14
You wish journal editorials were half this good
3
24
113
45,398
Murat Çap, MD retweeted
7 Dec 2025
Bunlar yetmedi👇
Akciğer damar hastalıklarında dünyanın tanıdığı Prof. Dr. Cihangir Kaymaz 32 yıldır en zorlu vakalara müdahale ederek hayat kurtarıyor, uzman hekim yetiştiriyor.
Sadece son bir haftada makaleleri 41 atıf aldı. Toplam 6 bin 709 atıfla, tüm bilim dalları içinde dünya ölçeğinde en üst yüzde 3’lük dilime giriyor.
Avrupa Pulmoner Hipertansiyon 2015 ve Pulmoner Emboli 2019 kılavuzlarının hazırlanmasında Türkiye adına görev aldı. Sağlık Bilimleri Üniversitesinin kuruluşu ardından ilk Kardiyoloji Anabilim Dalı Başkanı olarak 3.5 yıl görev yaptı. Ayrıca Türk Kardiyoloji Derneği Pulmoner Vasküler Hastalıklar ve Erişkin Doğumsal Kalp Hastalıkları Çalışma Grubunun kurucu başkanıydı.
diken.com.tr/nadir-hastalikl… @dikencomtr aracılığıyla
6
43
199
34,912
Murat Çap, MD retweeted
8 Jul 2025
1
3
4
792
9 Feb 2022
Diyarbakır Gazi Yaşargil Eğitim ve Araştırma Hastanesindeki ilk TAVI işlemini başarıyla gerçekleştirdik.Desteklerinden ötürü @canyucelkarabay’a teşekkürler.@m_degertekin @ihtanboga @alikaragozmd @emraherdoganmd @scaganefe @mirhanbahar21 @onurtasar @gokselcinier
2
4
32